Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
STAT+
Biotech

Failure to Report: A STAT investigation

By Jeffery DelViscio Dec. 11, 2015

Reprints

What we found: Most research institutions — including leading universities and hospitals in addition to drug companies — routinely break a law that requires them to report the results of human studies of new treatments to the federal government’s ClinicalTrials.gov database.

Read: Law ignored, patients at risk

Interactive: Explore the performance of top research institutions in academia, industry, and government.

Read more: How we did the project.

Have you participated in a clinical trial? Take our survey.

About the Author Reprints

Jeffery DelViscio

Contributing Editor (on leave)

How Mindstrong’s rush to roll out a ‘smoke alarm’…
How Mindstrong’s rush to roll out a ‘smoke alarm’ for mental illness led to its downfall
Researching collagen to help his achy knees, a statistician…
Researching collagen to help his achy knees, a statistician explores the painfully weak evidence
23andMe had devastating news about my health. I wish…
23andMe had devastating news about my health. I wish a person had delivered it
Takeda autoimmune therapy shows effectiveness in key trial
Takeda autoimmune therapy shows effectiveness in key trial
Targeting cancer: the new frontier of immunotherapy and precision…
Targeting cancer: the new frontier of immunotherapy and precision oncology
Following your gut: How scientists are getting closer to…
Following your gut: How scientists are getting closer to linking the microbiome and chronic diseases

Recommended Stories